AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Jazz Pharmaceuticals plc Director's Dealing 2024

Jul 31, 2024

30751_dirs_2024-07-30_50a1b01d-1d32-4412-b6e7-49134ed75404.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2024-07-25

Reporting Person: Hamill Laura (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Ordinary Shares	1500	Direct